Jona Mata, MD (@jonamata26) header
Jona Mata, MD (@jonamata26) profile picture

Oncology Fellow @hopkins_hemonc | MedEd | Onc Nerd @tumortalks | Proud @tamumedicine, @utaustin & @oslerresidency grad 🤘🏼

Joined September 2020
Photo by Jona Mata, MD (@jonamata26)Photo by Jona Mata, MD (@jonamata26)Photo by Jona Mata, MD (@jonamata26)Photo by Jona Mata, MD (@jonamata26)Photo by Jona Mata, MD (@jonamata26)Photo by Jona Mata, MD (@jonamata26)Photo by Jona Mata, MD (@jonamata26)Photo by Jona Mata, MD (@jonamata26)
I matched at Johns Hopkins! This is for that young girl in Cagayan De Oro City, Philippines who thought that being a doctor was something that was highly improbable. This is for big dreamers everywhere. What a day, what a dream to learn from the best! #MatchDay2021 #tamumedicine
30
50
5
1,259
Jona Mata, MD retweeted
Presented at #ESMO24: Among patients with limited-stage small-cell lung cancer, overall and progression-free survival were significantly longer with durvalumab adjuvant therapy added to standard concurrent chemoradiotherapy. Full ADRIATIC trial results: nej.md/4d0eZ5m
83
14
172
48,235
The future residents at @rwjmsmedicine are so lucky to have you, Bryan! The best teacher and mentor. 🥇
This Post is from an account that no longer exists. Learn more
5
1,044
Jona Mata, MD retweeted
Super honored to be among this group of amazing @HopkinsMedicine educators: @tinazhangmd @KotwalSusrutha @dromron @dc1116 @Rock1MD. Thanks @Hopkins_IEE for the recognition and for making Hopkins such a wonderful community for #MedEd educators!
5
8
4
54
7,250
Jona Mata, MD retweeted
Scratching your head thinking about Head and Neck cancers? Us too. Listen to this week’s new episode with Dr. Lara Dunn of @MSKCC_OncoNotes!
2
2
704
Proud to share our findings on Primary and Secondary Graft Failure in patients receiving AlloHSCT + PTCy as GVHD prophylaxis A very special thanks to my grand-ACS Dr. Alex Ambinder for his awesome mentorship astctjournal.org/article/S26…
1
3
26
2,624
Proud to author this piece in @JACCJournals Women’s CV disease remains under-recognized and under-treated, but the 2023 CCD guidelines offer important guidelines for treating female patients with ASCVD. Extra thanks to @GarimaVSharmaMD and @rblument1 bit.ly/23ccd
1
5
19
1,949
Exceptional teaching by @jonamata26 and John Connolly today at @OslerResidency Barker Firm Grand Rounds. “The Hepatic Head-Scratcher: A Curious Case of Acute Liver Failure” Fascinating case that turned out to have hemophagocytic lymphohistiocytosis secondary to anaplasmosis.
1
3
1
31
2,993
Jona Mata, MD retweeted
The addition of subcutaneous daratumumab to bortezomib, lenalidomide, and dexamethasone therapy and to lenalidomide maintenance therapy had a significant benefit on progression-free survival among patients with multiple myeloma. Full PERSEUS trial results: nej.md/3Nm3j33
2
43
1
109
29,905
That’s my best friend!! 🤩 @Armani_Hawes #BarkerPride #OslerPride
Fearless barker SAR and to-be ACS Armani Hawes (@Armani_Hawes) winning the iron med competition at ACP 2024!!! (@OslerResidency) #oslerpride
1
13
2,814
Extremely humbled, honored and excited to serve as a future @OslerResidency ACS with this all-star team and a real life Wonder Woman at the helm of it all. To be able to teach what my teachers taught me is truly a dream come true! @BBroderickMD @Armani_Hawes
9
8
4
96
21,891
I’m so excited to continue the dream of training at Hopkins now as a future Oncologist!! 🩸👩🏻‍⚕️An honor to match @Hopkins_HemOnc and excited to continue to learn from the best. A big thank you to my family & teachers who got me here today, this one is for you! @OslerResidency
We are thrilled to introduce our incoming @Hopkins_HemOnc fellowship class - what a brilliant & inspiring group of physicians. Can't wait to have you all here in Baltimore! @hopkinskimmel @kamarroneMD @redcell_doc @JZimmermanMDPhD @LeukDocWebster @MarkYarchoan #AnaDeJesusAcosta
5
1
1
97
12,312
Jona Mata, MD retweeted
Urine for a great episode talking about Non-Muscle Invasive Bladder Cancer with amazing Urologic Oncologist, Dr. @HongTruongMD of Penn State! Listen to this week's episode for plenty of pearls. spotifyanchor-web.app.link/e…
3
7
864
Jona Mata, MD retweeted
Don't liver us hanging, listen to this amazing HCC episode with @Hopkins_HemOnc expert, Dr. Mark Yarchoan in this week's Tumor Talks episode! 🔗spotifyanchor-web.app.link/e… #MedEd #HCC #OncMedEd
4
10
2,358
Jona Mata, MD retweeted
Ahead of World MDS Day, we wanted to talk about an important myeloid neoplasm, Myelodysplastic Syndrome (MDS). We are fortunate to have our expert and former @oslerresidency ACS, Dr. Amy Dezern break down the basics of MDS. Learn more in this week's episode of Tumor Talks!
5
8
1,951
Jona Mata, MD retweeted
Did you know Hodgkin Lymphoma can lead to itching and pain with alcohol use? Interesting stuff! This week, we go back to talking about liquid malignancies with our very own, @willsbeatriz. Learn more interesting bits about Hodgkin beyond Reed-Sternberg in this week's episode!
2
4
655
Jona Mata, MD retweeted
During breast cancer awareness month, we want to talk about the most common cause of cancer death in women worldwide. Listen to this great episode on breast cancer with Dr. Jessie Tao to learn more! 🎀 🔗podcasters.spotify.com/pod/s… @jonamata26 @Hopkins_HemOnc @BeatrizWills
3
8
1,258
I called this 3 years ago 👀! Truly deserving, Dr. Karikó. 🧬🥼🏆
As the vaccine rollout begins, let’s not forget that a female scientist, Dr. Karikó, spearheaded this paradigm shift in vaccine creation! Worthy of a Nobel prize! 🤩 #MedStudentTwitter #MedTwitter #WomenInSTEM google.com/amp/s/www.telegra…
12
927
Excited to finally talk about liquid malignancies in this @tumortalks episode with Dr. Jonathan Webster!🩸🦴💥
Equally as important, we segue to liquid malignancies this week. This week's episode is a 101 on AML with @Hopkins_HemOnc expert and former @oslerresidency ACS, Dr. Jonathan Webster. We promise, this one's a BLAST! 🩸💥🧬 🔗podcasters.spotify.com/pod/s…
9
759